The benefits of GLP-1 drugs beyond obesity.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39024455.
- Also identified by DOI 10.1126/science.adn4128.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glucagon-like peptide-1-based medicines have weight loss-independent actions.
Medical subject headings
- Cardiovascular System
- Glucagon-Like Peptide 1
- Glucagon-Like Peptides
- Weight Loss